SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-061260
Filing Date
2021-10-21
Accepted
2021-10-21 16:50:51
Documents
2
Period of Report
2021-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2941
2 POA DOCUMENT poa.txt EX-24 3027
  Complete submission text file 0001209191-21-061260.txt   7406
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REZOLUTE, INC. 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address
Miller Seline E. (Reporting) CIK: 0001769866 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 211337545